# NIH Reporter #PAR-21-321

Translational Oncology Research Program

**Recipient:** National Cancer Institute (NCI), part of the National Institutes of Health (NIH)

**Award Amount:** $37,947.00
**Ceiling:** $37,947.00

**Awarded:** July 20, 2026

**Identifier:** PAR-21-321

Award for translational oncology research to develop new anticancer agents and conduct clinical trials, funded by NIH/NCI with approximately $37,947.

### Description

The project focuses on translational oncology research aimed at identifying novel targets, developing new anticancer agents, and leading clinical trials to reduce cancer incidence and mortality, particularly in Kentucky. The project involves collaboration among multiple investigators and institutions, with a focus on precision medicine and biomarker development.

[View original record](https://reporter.nih.gov/search/0C83gI3MXki4-tEhFD4UKQ/project-details/11414934)